Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I T Boyle

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
Archives of Disease in Childhood|May 1, 1991
Malignant osteopetrosis: hypercalcaemia after bone marrow transplantationP S Rawlinson, R H Green, A M Coggins, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1971
The mechanism of adaptation of intestinal calcium absorption to low dietary calciumI T Boyle, R W Gray, J L Omdahl, et al.
Lancet (London, England)|July 30, 1988
Treatment of severe hypercalcaemia with mithramycin and aminohydroxypropylidene bisphosphonateS H Ralston, S J Gallacher, F J Dryburgh, et al.
Annals of the Rheumatic Diseases|December 1, 1991
Clinical experience with pamidronate in the treatment of Paget's disease of boneS J Gallacher, B F Boyce, U Patel, et al.
Acta Endocrinologica|August 1, 1983
PTH and vitamin D responses during treatment of hypomagnesaemic hypoparathyroidismS Ralston, I T Boyle, R A Cowan, et al.
Lancet (London, England)|March 24, 1990
Use of bisphosphonates in hypercalcaemia due to malignancyS H Ralston, S J Gallacher, U Patel, et al.
Lancet (London, England)|December 11, 1993
Mineralisation defects with pamidronate therapy for Paget's diseaseB B Adamson, S J Gallacher, J Byars, et al.
Lancet (London, England)|January 29, 1994
Length of published reportsB F Boyce, B B Adamson, S J Gallacher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1978
The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone diseaseI Fogelman, R G Bessent, J G Turner, et al.
Biochemistry|November 7, 1972
Isolation and identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D made in the kidneyM F Holick, H K Schnoes, H F DeLuca, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Archives of Disease in Childhood|May 1, 1991
Malignant osteopetrosis: hypercalcaemia after bone marrow transplantationP S Rawlinson, R H Green, A M Coggins, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1971
The mechanism of adaptation of intestinal calcium absorption to low dietary calciumI T Boyle, R W Gray, J L Omdahl, et al.
Lancet (London, England)|July 30, 1988
Treatment of severe hypercalcaemia with mithramycin and aminohydroxypropylidene bisphosphonateS H Ralston, S J Gallacher, F J Dryburgh, et al.
Annals of the Rheumatic Diseases|December 1, 1991
Clinical experience with pamidronate in the treatment of Paget's disease of boneS J Gallacher, B F Boyce, U Patel, et al.
Acta Endocrinologica|August 1, 1983
PTH and vitamin D responses during treatment of hypomagnesaemic hypoparathyroidismS Ralston, I T Boyle, R A Cowan, et al.
Lancet (London, England)|March 24, 1990
Use of bisphosphonates in hypercalcaemia due to malignancyS H Ralston, S J Gallacher, U Patel, et al.
Lancet (London, England)|December 11, 1993
Mineralisation defects with pamidronate therapy for Paget's diseaseB B Adamson, S J Gallacher, J Byars, et al.
Lancet (London, England)|January 29, 1994
Length of published reportsB F Boyce, B B Adamson, S J Gallacher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1978
The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone diseaseI Fogelman, R G Bessent, J G Turner, et al.
Biochemistry|November 7, 1972
Isolation and identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D made in the kidneyM F Holick, H K Schnoes, H F DeLuca, et al.
Pageof 12